Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.
NCT03458624
·
clinicaltrials.gov ↗
UNKNOWN
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Sponsor
Kang Stem Biotech Co., Ltd.